TAP, Express Scripts Receive Boston Subpoenas Related To Lupron, Prevacid
Executive Summary
TAP Pharmaceuticals is responding to a second request for documents related to Lupron and Prevacid from the Boston U.S. Attorney's Office
You may also be interested in...
PBMs Will Emerge From “Regulatory Cloud” Soon, Express Scripts Predicts
The investigations of pharmacy benefit management practices will take up to three more years to resolve, Express Scripts CFO Edward Stiften predicted during the Bear Stearns conference in New York Sept. 13
PBMs Will Emerge From “Regulatory Cloud” Soon, Express Scripts Predicts
The investigations of pharmacy benefit management practices will take up to three more years to resolve, Express Scripts CFO Edward Stiften predicted during the Bear Stearns conference in New York Sept. 13
TAP employee indictments
TAP Pharmaceuticals has placed four employees on administrative leave following indictments by Boston U.S. Attorney's Office July 16; two former employees were also indicted. The additional changes have no impact on TAP itself; the company previously agreed to an $875 mil. fine to settle charges related to its pricing and marketing practices. The Boston U.S. Attorney's Office has subpoenaed Express Scripts, Caremark and WellPoint for information regarding Lupron and Prevacid (1"The Pink Sheet" May 6, p. 14)...